+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Plasma Protein Therapeutic Market by Product Type, by Application, and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

  • ID: 4854293
  • Report
  • September 2018
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the Plasma Protein Therapeutic Market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the Plasma Protein Therapeutic Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Plasma Protein Therapeutic Market on a global level.

In order to give the users of this report a comprehensive view of the Plasma Protein Therapeutic Market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses product type, application segmentation, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the Plasma Protein Therapeutic Market by segmenting the market based on product type, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on product type, Plasma Protein Therapeutic Market has been segmented into coagulation factors, immunoglobulin, alpha-1 proteinase inhibitor, and albumin. Based on applications, Plasma Protein Therapeutic Market has been segmented into hemophilia, primary immunodeficiency disorder, idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and other indications.

The growing usage of the plasma proteins derived medicines is a major driver of the market growth during the forecast period. Additionally, the introduction of new plasma-derived therapies are the major factors which drive the patient segment in Plasma Protein Therapeutic Market with the highest CAGR during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further divided into major countries including the U.S., Germany, France, the U.K., China, Japan, India, and Brazil. This segmentation includes demand for Plasma Protein Therapeutic Market based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Octapharma, CSL limited, Baxter, Telecris, Grifols, Kedrion, and Chengdu Inst. Japan Red Cross, LFB Group, Shanghai Blood Institute, BPL Group, and Sanquin are some of the nonprofit organizations that are also playing a vital role in Plasma Protein Therapeutic Market market.

This report segments the global Plasma Protein Therapeutic Market as follows:

Global Plasma Protein Therapeutic Market: By Product Type

  • Coagulation factors
  • Immunoglobulin
  • Alpha-1 proteinase inhibitor
  • Albumin

Global Plasma Protein Therapeutic Market: By Applications

  • Hemophilia
  • Primary immunodeficiency disorder
  • Idiopathic thrombocytopenic purpura
  • Secondary immunodeficiency
  • Hereditary angioedema
  • Other indications

Global Plasma Protein Therapeutic Market: By Region

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • The Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Plasma Protein Therapeutic Market, 2015 - 2024 (USD Billion)
    • 2.2. Global Plasma Protein Therapeutic Market: Snapshot
  • Chapter 3. Plasma Protein Therapeutic Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Plasma Protein Therapeutic Market drivers: Impact analysis
      • 3.2.2. Increasing usage of the plasma proteins derived medicines
      • 3.2.3. Introduction of new plasma-derived therapies
    • 3.3. Market Restraints
      • 3.3.1. Implementation of stringent regulatory policies
      • 3.3.2. Issues pertaining to reimbursements
    • 3.4. Opportunities
      • 3.4.1. Increase in demand for plasma-derived treatments, rise in medical tourism, and increase in disposable income
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by Regional Segment
  • Chapter 4. Global Plasma Protein Therapeutic Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Plasma Protein Therapeutic Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  • Chapter 5. Global Plasma Protein Therapeutic Market - Product Type Segment Analysis
    • 5.1. Global Plasma Protein Therapeutic Market: Product Type overview
      • 5.1.1. Global Plasma Protein Therapeutic Market revenue share, by Product Type, 2015 and 2024(USD Billion)
    • 5.2. Coagulation Factors
      • 5.2.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 5.3. Immunoglobulin
      • 5.3.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 5.4. Alpha-1 Proteinase Inhibitor
      • 5.4.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 5.5. Albumin
      • 5.5.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
  • Chapter 6. Global Plasma Protein Therapeutic Market - Application Segment Analysis
    • 6.1. Global Plasma Protein Therapeutic Market: Application overview
      • 6.1.1. Global Plasma Protein Therapeutic Market revenue share, by Application, 2015 and 2024(USD Billion)
    • 6.2. Hemophilia
      • 6.2.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.3. Primary immunodeficiency disorder
      • 6.3.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.4. Idiopathic Thrombocytopenic Purpura
      • 6.4.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.5. Secondary immunodeficiency
      • 6.5.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.6. Hereditary Angioedema
      • 6.6.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
    • 6.7. Other indications
      • 6.7.1. Global Plasma Protein Therapeutic Market, 2015 - 2024(USD Billion)
  • Chapter 7. Global Plasma Protein Therapeutic Market - Regional Segment Analysis
    • 7.1. Global Plasma Protein Therapeutic Market: Regional overview
      • 7.1.1. Global Plasma Protein Therapeutic Market revenue share, by Region, 2015 and 2024
    • 7.2. North America
      • 7.2.1. North America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.2.2. North America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.2.3. North America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.2.4.2. The U.S. Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.2.4.3. The U.S. Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.2.5.2. Rest of North America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.2.5.3. Rest of North America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.3.2. Europe Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.3.3. Europe Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.4.2. Germany Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.4.3. Germany Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.5. U.K.
        • 7.3.5.1. U.K. Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.5.2. U.K. Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.5.3. U.K. Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.6. France
        • 7.3.6.1. France Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.6.2. France Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.6.3. France Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.3.7.2. Rest of Europe Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.3.7.3. Rest of Europe Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.4.2. Asia Pacific Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.4.3. Asia Pacific Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.4.2. China Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.4.3. China Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.5.2. Japan Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.5.3. Japan Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.6.2. India Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.6.3. India Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.4.7.3. Rest of Asia Pacific Plasma Protein Therapeutic Market revenue, by region, 2015 - 2024(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.5.2. Latin America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.5.3. Latin America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.5.4.2. Brazil Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.5.4.3. Brazil Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
        • 7.5.5.2. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
        • 7.5.5.3. Rest of Latin America Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Product Type, 2015 - 2024(USD Billion)
      • 7.6.2. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Application, 2015 - 2024(USD Billion)
      • 7.6.3. The Middle East and Africa Plasma Protein Therapeutic Market revenue, by Region, 2015 - 2024(USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Octapharma
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. CSL Limited
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Baxter
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Telecris
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Grifols
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Kedrion
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Chengdu Inst.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll